Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,076–1,100 of 27,380 studies, newest first · page 44 of 1096.

June 2026 25

  1. 2026-06-18

    Promoting Brain Health in the Context of Normal Aging and Mild Cognitive Impairment: A Tutorial

    ✓ Peer-reviewed Health systems and care delivery American journal of speech-language pathology

    Key finding: There are significant opportunities for speech-language pathologists (SLPs) to play important roles in the primary and secondary prevention of Alzheimer's disease and related dementias (ADRD) beyond current practices. +1 more finding

  2. 2026-06-18

    Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: = 0.007) in AD-signature regions and a numerically higher burden of vascular risk factors. +4 more findings

  3. 2026-06-18
  4. 2026-06-17
  5. 2026-06-17
  6. 2026-06-17

    Attention Networks Connectivity After Cognitive Rehabilitation in Alzheimer’s Disease

    ✓ Peer-reviewed Brain scans and imaging Journal of Geriatric Psychiatry and Neurology

    Key finding: Enhanced connectivity between attention networks may be a characteristic of CR benefits in individuals with mild Alzheimer disease. +2 more findings

  7. 2026-06-16

    Anticuerpos monoclonales antiamiloide y enfermedad de Alzheimer: ¿estamos preparados?

    ✓ Peer-reviewed Genetics Kranion

    Key finding: ResumenLa llegada de los anticuerpos monoclonales lecanemab y donanemab marca un cambio de paradigma en el tratamiento de la enfermedad de Alzheimer, transitando del nihilismo terapéutico a la era de las terapias modificadoras de la enfermedad.

  8. 2026-06-15

    Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses

    ⚠ Preprint — not yet peer-reviewed Costs and economics PsyArXiv

    Key finding: Higher prevalence was observed in the ID group relative to the general population for epilepsy, young-onset ADRD, and their comorbidity. +4 more findings

    Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-06-15

    Microplastics-Induced Gut Microbiota Dysbiosis Accelerates Alzheimer's-Like Pathology and Cognitive Decline via the Gut-Brain Axis

    ✓ Peer-reviewed Disease mechanisms Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Key finding: Translational validation using Alzheimer's Disease Neuroimaging Initiative (ADNI) plasma shows taurine is significantly lower in AD patients versus cognitively normal controls and inversely correlates with cognitive decline. +1 more finding

  10. 2026-06-15

    Moving long-term care insurance upstream: A geriatric-syndrome-oriented framework for healthy aging in China

    ✓ Peer-reviewed Health systems and care delivery Bioscience trends

    Key finding: Existing quasi-experimental studies from China suggest that current LTCI pilots are associated with partial benefits in cognitive and psychological outcomes, changes in healthcare utilization including reduced hospitalization in some studies, modest improvements in health-related quality of life, and favorable frailty-related outcomes.

  11. 2026-06-15

    Development and Co‐Production of POST‐ID: A Post‐Diagnostic Behaviourally Informed Psychosocial Dementia Intervention for Adults With Intellectual Disabilities

    ✓ Peer-reviewed Health systems and care delivery British Journal of Learning Disabilities

    Key finding: Stakeholder feedback led to substantive refinements, including delivery across six structured sessions, prioritisation of emotional safety and identity preservation, and explicit focus on carer‐mediated behaviour change. +4 more findings

  12. 2026-06-12

    ActiTect: a generalizable machine learning pipeline for REM sleep behavior disorder screening through standardized actigraphy

    ✓ Peer-reviewed Digital health tools npj Digital Medicine

    Key finding: While wrist-worn actimeters hold significant potential for detecting RBD in large-scale screening efforts by capturing abnormal nocturnal movements, they require a reliable and efficient analysis pipeline. +2 more findings

  13. 2026-06-11
  14. 2026-06-11

    Agricultural pesticide use and Alzheimer’s disease dementia prevalence across US counties in a mixed supervised–unsupervised analysis

    ✓ Peer-reviewed Risk factors Scientific Reports

    Key finding: Out of 462 total pesticides screened, 112 demonstrated high selection stability and were grouped into 25 exposure clusters. +2 more findings

  15. 2026-06-10

    Crossmodal plasticity effects of hearing loss and ageing in the human auditory cortex

    ⚠ Preprint — not yet peer-reviewed Risk factors bioRxiv

    Key finding: ARHL is prevalent in a large proportion of older adults, and it is associated with an increased risk of cognitive decline and dementia. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-06-10

    Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment NPJ digital medicine

    Key finding: The MCI group showed greater decline than the CU group in the familiarity-dependent task, while stratifying the MCI group by beta-amyloid (Aβ) status (n = 21 Aβ-; n = 24 Aβ+) revealed greater change in memory precision for objects and familiarity-dependent memory in the MCI Aβ+ group. +1 more finding

  17. 2026-06-10

    Advance Care Planning and End-of-Life Care in Elderly: A Twenty-Four Month Cohort of Three Hundred and Fifty-Eight Patients with Serious Advanced Illness Advance Care Planning Cascade, Goals-of-Care Concordance, and Determinants Across Four Frailty Strata

    ✓ Peer-reviewed End-of-life care Zenodo (CERN European Organization for Nuclear Research)

    Key finding: ACP engagement cascaded through enrolment (86.0%), initial conversation (73.7%), goals of care documentation (60.9%), treatment preferences (49.7%), and accessible documents at end-of-life (41.3%). +4 more findings

  18. 2026-06-10

    Advance Care Planning and End-of-Life Care in Elderly: A Twenty-Four Month Cohort of Three Hundred and Fifty-Eight Patients with Serious Advanced Illness Advance Care Planning Cascade, Goals-of-Care Concordance, and Determinants Across Four Frailty Strata

    ✓ Peer-reviewed End-of-life care Zenodo (CERN European Organization for Nuclear Research)

    Key finding: ACP engagement cascaded through enrolment (86.0%), initial conversation (73.7%), goals of care documentation (60.9%), treatment preferences (49.7%), and accessible documents at end-of-life (41.3%). +4 more findings

  19. 2026-06-10

    National Trends and Demographic Disparities in Mortality Involving Co-Recorded Parkinson’s Disease and Dementia in the United States, 1999–2025: A CDC WONDER Analysis

    ✓ Peer-reviewed Disparities NeuroSci

    Key finding: A sharp transient increase occurred in 2020, attributable to pandemic-related factors including disproportionate COVID-19 mortality among older adults with neurodegenerative conditions, care disruptions, and changes in death-certificate coding practices. +4 more findings

  20. 2026-06-09

    Age-Related Speech-in-Noise Hearing Loss in Parkinson’s Disease and APOE E4 Carriers

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: The apolipoprotein E ( APOE ) E4 allele is the strongest genetic risk factor for Alzheimer’s disease and is associated with cognitive decline in PD, yet its relationship to hearing loss remains unclear. +3 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  21. 2026-06-09

    Functional-vs-Cognitive Decline Heterogeneity in Alzheimer’s Disease: LLM-Curation of Decades of Clinical Notes and GLP1RA Trial Design

    ⚠ Preprint — not yet peer-reviewed Drug development Preprints.org

    Key finding: Compared with matched non-AD controls, AD patients had lower ADCS-MCI-ADL scores at year 4 (28.1 versus 47.0 points; P<0.001) and higher FAQ impairment across follow-up. +2 more findings

    Scored 34 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  22. 2026-06-09

    Semaglutide attenuates neuroinflammation in male mice

    ✓ Peer-reviewed Drug development Nature communications

    Key finding: Together, these findings reveal how GLP-1R signaling in male mice orchestrates resolution of neuroinflammation through coordinated multi-cellular programs.

  23. 2026-06-09

    Blood-based biomarkers for dementia with Lewy bodies

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: Reliable biomarkers are necessary, since a definitive diagnosis of DLB currently requires postmortem tissue analysis. +4 more findings

  24. 2026-06-09

    Lifestyle Interventions for Cognitive Decline and Dementia Prevention: A Network Meta-analysis (P9-13.014)

    ✓ Peer-reviewed Prevention trials Neurology

    Key finding: To compare and rank the relative and additive effects of lifestyle components including exercise, diet, cognitive training, vascular management, and digital delivery on cognitive outcomes and dementia prevention in older adults without dementia.

  25. 2026-06-09

    Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice

    ✓ Peer-reviewed Brain tissue and pathology Neurobiology of Disease

    Key finding: Grn +/− :hTDP+ mice exhibited more dramatic impairment of social dominance than either Grn +/− or hTDP+ mice, which was associated with combined effects of progranulin insufficiency and hTDP expression on dendritic spines of neurons in the medial prefrontal cortex (mPFC). +1 more finding

Browse the library by subject, with the full score breakdown →